Promega has launched the Maxwell CSC instrument and integrated reagent kits for blood DNA and DNA FFPE. The solutions have been developed in compliance with the FDA’s Quality System Regulation and are intended as in vitro diagnostic (IVD) medical devices. Complying with these stringent requirements ensures consistent performance between instruments and runs.
The technology extracts nucleic acid using novel paramagnetic particles, allowing optimal capture, wash and elution of the target material. Because there are no tubes or pipette tips involved, there are no clogs, drips, splashing or aerosols, reducing any contamination risk. Depending on which specific CSC kits are used (for blood or FFPE tissues), the instrument can purify DNA from up to 16 samples in under 45 min of processing time, providing high-quality nucleic acids appropriate for downstream analysis in amplification-based assays.
The system’s Windows 7-based touch-screen interface provides laboratories with the ability to easily track samples, instrument self-check reports, kit lot number and expiration dates, and operator usage, and to document parameters and protocols.
Phone: 03 9818 1466
Lonza 4D-Nucleofector LV Unit PRO electroporation unit
Lonza's 4D-Nucleofector LV Unit PRO is a next-generation, large-scale electroporation unit...
Cytek 25-Color Immunoprofiling Assay, cFluor Reagent Kit (18C)
The Cytek 25-Color Immunoprofiling Assay has been designed and optimised to provide a turnkey...
Bio-Rad Laboratories QX Continuum and QX700 series ddPCR platforms
The latest platforms complement Bio-Rad's existing QX ddPCR portfolio and offer users...